Staff turnover in EUR133,295160,223179,078177,951176,594
Staff turnover in EUR133,295160,223179,078177,951176,594
The share: stated in EUR20212022202320242025
Shares outstanding (in mn.)21.8521.8521.8521.8521.85
Dividend per share-----
Basic earnings per share-0.25-0.30-0.38-0.51-0.54
P/L in EUR million under IAS/IFRS20212022202320242025
Turnover38.449.555.354.649.6
Operating income (EBIT)-2.0-3.2-5.1-8.5-9.5
Earnings before taxes-2.6-3.7-6.0-10.5-11.5
Annual net profit/ loss-5.0-6.6-8.3-11.1-11.7
Balance sheet in EUR million under IAS/IFRS20212022202320242025
Assets
Total current assets39.130.425.545.725.0
Total fixed assets38.647.645.543.141.4
Total assets77.778.070.988.766.3
Liabilities
Total short-term liabilities11.321.417.525.017.6
Total long-term liabilities24.622.430.449.846.9
Total provisions2.31.20.90.90.7
Equity capital41.834.223.013.91.8
Total liabilities77.778.070.988.766.3
Management:
Adriaan Moelker
Michael Schneiders
Board:
Michael Majerus
Anna Carina Eichhorn
Florian Schnabel
Ursula La Cognata
Christine Uekert
Stephen Catling
Shareholding in %:
Daniel Hopp 5.60
Deka Investment GmbH 1.89
FPM Frankfurt Performance Management AG 1.65
Generali Investments LLC 0.17
KBC Asset Management NV 0.27
MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH 1.51
Martin Putsch 31.50
Pbg Zweite GmbH 15.10
SMS & Cie. Vermögensmanagement GmbH 0.09
Universal-Investment-Gesellschaft mbH (Invt Mgmt) 2.99
Freefloat 39.24
Address: Darmstädter Strasse 34-36, 64673 Zwingenberg
T: +49-6251-9331-0
F: +
I: http://www.brain-biotech.de
E: [email protected]